Market news
Detailed price information for Lensar Inc (LNSR-Q) from The Globe and Mail including charting and trades.
Detailed price information for Lensar Inc (LNSR-Q) from The Globe and Mail including charting and trades.
Detailed price information for Lensar Inc (LNSR-Q) from The Globe and Mail including charting and trades.
Detailed price information for Pyxis Oncology Inc (PYXS-Q) from The Globe and Mail including charting and trades.
LENSAR Inc (LNSR) posts 18% revenue growth and its strongest adjusted EBITDA to date, driven by a 20% jump in recurring revenue and expanding US market share.
LENSAR (NASDAQ:LNSR) reported second-quarter 2026 revenue growth of 18% as the company continued to rebuild commercial momentum following the termination of its proposed merger with Alcon near the end of the first quarter. Chief Executive Officer Nick Curtis said the company returned to operating i
Moby summary of LENSAR, Inc.'s Q2 2026 earnings call
10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026 Second Quarter Recurring Revenue was $13.7 million Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, tod
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Detailed price information for Lensar Inc (LNSR-Q) from The Globe and Mail including charting and trades.
ORLANDO, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s second quarter 2026 financial results will be released before market open on Thursday, August 13, 2026. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, August 13, 2026 to discuss the results, recent corporate
This is the newest page. Registered accounts read further back.